Clinical Trial Update: Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia [Phase 3]

View source ↗

Summary

Phase 3 trial of iron isomaltoside 1000 (Monofer) in non-dialysis-dependent chronic kidney disease with renal-related anemia has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency Anemia, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-12-03